Eikon Therapeutics is a mission-driven biopharmaceutical company at the cutting edge of scientific discovery. By pioneering the use of proprietary microscopy technology, the company enables molecular-resolution measurements within living cells, allowing researchers to observe and understand biology in ways previously thought impossible.
Eikon's success is built upon the convergence of diverse scientific disciplines. By bringing together experts in engineering, computational science, chemistry, and biology, the organization tackles some of the most difficult challenges in medicine to bring life-saving treatments to patients. It is a place for innovators looking to redefine the future of pharmaceutical development.